Market Indices
Sector Heatmap
ORIC — Oric Pharmaceuticals, Inc. Common Stock
NasdaqOric Pharmaceuticals, Inc. Common Stock
- O
- 11.83
- H
- 12.43
- L
- 11.81
- V
- 790.76K
ORIC — Latest News & Headlines
20 StoriesSix new hires received options to buy shares and stock awards from ORIC Pharmaceuticals - Stock Titan
Six new hires received options to buy shares and stock awards from ORIC Pharmaceuticals Stock Titan
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Stock Has Average Target Price of $20.18 - MarketBeat
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Stock Has Average Target Price of $20.18 MarketBeat
ORIC Falls After Hours On Safety Concerns Around Prostate Cancer Candidate At Higher Doses - Stocktwits
ORIC Falls After Hours On Safety Concerns Around Prostate Cancer Candidate At Higher Doses Stocktwits
Oric Pharma CFO sells $181k in shares - Investing.com
Oric Pharma CFO sells $181k in shares Investing.com
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
ORIC Pharmaceuticals (ORIC) Gains A De Risked Path As Undervalued Case Holds - Simply Wall Street
ORIC Pharmaceuticals (ORIC) Gains A De Risked Path As Undervalued Case Holds Simply Wall Street
Leerink starts coverage on ORIC Pharmaceuticals stock with USD 26 target - AD HOC NEWS
Leerink starts coverage on ORIC Pharmaceuticals stock with USD 26 target AD HOC NEWS
Oric Pharmaceuticals (ORIC) Partners with Cancer Research UK to Advance ORIC-259 Clinical Trials - GuruFocus
Oric Pharmaceuticals (ORIC) Partners with Cancer Research UK to Advance ORIC-259 Clinical Trials GuruFocus
Cancer Research UK will fund early testing of a potential cancer treatment. - Stock Titan
Cancer Research UK will fund early testing of a potential cancer treatment. Stock Titan
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Down 4.6% - Here's What Happened - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Down 4.6% - Here's What Happened MarketBeat
Oric Pharmaceuticals CFO Dominic Piscitelli sells $8,102 in shares - Investing.com
Oric Pharmaceuticals CFO Dominic Piscitelli sells $8,102 in shares Investing.com
A finance chief exercised 600 options and sold 600 shares at Oric Pharmaceuticals (ORIC). - Stock Titan
A finance chief exercised 600 options and sold 600 shares at Oric Pharmaceuticals (ORIC). Stock Titan
Oric Pharmaceuticals (NASDAQ:ORIC) CFO Sells $181,302.00 in Stock - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) CFO Sells $181,302.00 in Stock MarketBeat
A director exercised options at $1.60 and sold 3,500 Oric Pharmaceuticals (ORIC) shares. - Stock Titan
A director exercised options at $1.60 and sold 3,500 Oric Pharmaceuticals (ORIC) shares. Stock Titan
1,078,055 Shares of Oric Pharmaceuticals, Inc. $ORIC Purchased by Bank of America Corp DE - MarketBeat
1,078,055 Shares of Oric Pharmaceuticals, Inc. $ORIC Purchased by Bank of America Corp DE MarketBeat
After a $4.36 option exercise, Oric Pharmaceuticals (ORIC) CFO sells 13,400 shares. - Stock Titan
After a $4.36 option exercise, Oric Pharmaceuticals (ORIC) CFO sells 13,400 shares. Stock Titan
Oric Pharmaceuticals (NASDAQ:ORIC) Coverage Initiated by Analysts at Leerink Partners - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) Coverage Initiated by Analysts at Leerink Partners MarketBeat
A proposed sale covers 7,600 Oric Pharmaceuticals (ORIC) shares held by RAHD Capital. - Stock Titan
A proposed sale covers 7,600 Oric Pharmaceuticals (ORIC) shares held by RAHD Capital. Stock Titan
A director proposes selling 8,100 shares of Oric Pharmaceuticals (ORIC). - Stock Titan
A director proposes selling 8,100 shares of Oric Pharmaceuticals (ORIC). Stock Titan
Trading Systems Reacting to (ORIC) Volatility - Stock Traders Daily
Trading Systems Reacting to (ORIC) Volatility Stock Traders Daily